QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 microbot-medical-announces-it-will-exhibit-its-liberty-endovascular-robotic-system-at-symposium-on-clinical-interventional-oncology-in-miami-fl-october-17-19-2025-marking-first-commercial-exhibition-of-the-system-following-its-fda-510k-clearance-in-september-2025

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributer of the innovative LIBERTY® Endovascular Robotic System, today an...

 hc-wainwright--co-reiterates-buy-on-microbot-medical-maintains-12-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 pr...

 microbot-medical-partners-with-us-based-3pl-company-to-support-commercialization-of-fda-cleared-liberty-system

The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support T...

 microbot-medical-announces-that-the-japanese-patent-office-has-granted-the-company-its-first-patent-in-japan-covering-the-core-liberty-system-technology

Commercial Focus Remains on U.S. Market as it Continues to Explore Certain Global Markets that Accept FDA Cleared Devices Prote...

 microbot-medical-enters-into-agreements-to-purchase-up-to-13989115-shares-of-common-stock-in-two-tranches-for-up-to-922m-in-gross-proceeds

Microbot Medical Inc. (NASDAQ:MBOT) ("Microbot" or the "Company"), today announced the entry into definitive ag...

 hc-wainwright--co-maintains-buy-on-microbot-medical-raises-price-target-to-12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Microbot Medical (NASDAQ:MBOT) with a Buy and raises the price ...

 microbot-medical-receives-fda-510k-clearance-for-liberty-robotic-system-targets-q4-2025-commercial-launch

Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025The Company's Initial Addressable M...

 us-patent-and-trademark-office-grants-microbot-medical-patent-covering-modular-robotic-surgical-system-includes-base-and-plurality-of-tool-receiver-units-arranged-as-separate-units-and-independently-and-interchangeably-attachable-to-base

 With the Newly Granted IP, the Company's IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and...

 microbot-medical-q2-eps-010-misses-008-estimate

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(...

 microbot-medical-announces-it-will-receive-a-non-dilutive-grant-from-the-israel-innovation-authority-in-the-amount-of-630k

Microbot Medical Inc. (NASDAQ:MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced it has been ap...

 microbot-medical-added-to-the-russell-microcap-index

Microbot Medical Inc. (NASDAQ:MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it was ad...

 microbot-medical-expands-commercial-team-ahead-of-anticipated-q3-2025-us-launch-of-liberty-robotic-system-fda-510k-decision-expected-q3-2025

Microbot Medical Inc. (NASDAQ:MBOT), developer of the innovative LIBERTY Endovascular Robotic System, today announced the conti...

 hc-wainwright--co-reiterates-buy-on-microbot-medical-maintains-9-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $9 pri...

 microbot-medical-presented-for-data-for-the-first-time-from-its-access-pvi-trial-at-the-society-of-interventional-radiology-annual-meeting

Successful robotic navigation was achieved in every case and met the primary endpoint of the studyLIBERTY® showed a 92% reducti...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION